Free shipping on all orders over $ 500

PLX7904

Cat. No. M9008
PLX7904 Structure
Synonym:

PB04

Size Price Availability Quantity
5mg USD 165  USD165 In stock
10mg USD 300  USD300 In stock
50mg USD 1350  USD1350 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PLX7904 is a potent and selective BRAF inhibitor, with IC50 of appr 5 nM against BRAFV600E in mutant RAS expressing cells. PLX7904 potently inhibit ERK1/2-driven GAL4-Elk1 reporter activity in PRT cells as well as parental cells. PLX7904 potently inhibits phosphorylation of ERK1/2 in mutant BRAF melanoma cells without eliciting paradoxical activation in wild-type BRAF, mutant NRAS melanoma cells.

In vivo, PLX7904 inhibits the COLO205 xenograft growth in eight mice per group.

Protocol (for reference only)
Cell Experiment
Cell lines WM793, WM115, WM9, WM278, WM1346, WM1366, WM1361A, Sbcl2, 1205Lu, A375, SK-MEL 24, SKMEL-2, and SK-MEL 207 cells
Preparation method Cells are treated with PLX7904 at different concentrations (0, 0.05, 0.1, 1, 5 μM) for 24 h. Cells are lysed and analyzed by Western blotting with phospho-MEK1/2, total MEK1/2, phospho-ERK1/2 and total ERK1/2 antibodies.
Concentrations 0, 0.05, 0.1, 1, 5 μM
Incubation time 24 h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 512.53
Formula C24H22F2N6O3S
CAS Number 1393465-84-3
Solubility (25°C) DMSO: ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Zhang C, et al. Nature. RAF inhibitors that evade paradoxical MAPK pathway activation.

[2] Basile KJ, et al. Pigment Cell Melanoma Res. Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors.

[3] Le K, et al. Pigment Cell Melanoma Res. Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells.

Related Raf Products
Cyclorasin 9A5

Cyclorasin 9A5 is an 11-residue cell-permeable cyclic peptide that orthosterically inhibits the Ras-Raf protein interaction with an IC50 of 120 nM.

R18

R18 is a peptide antagonists of 14-3-3, with a KD of 70-90 nM.

PROTAC RAF degrader 1

PROTAC RAF degrader 1 is a PROTAC RAF degrader.

B-Raf IN 15

B-Raf IN 15 is a BRAF inhibitor.

Raf inhibitor 3

Raf inhibitor 3 is a Raf inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: PLX7904, PB04 supplier, Raf, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.